cyproheptadine/prazosin (KT-110) / Kinnov Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyproheptadine/prazosin (KT-110) / Kinnov Therap
COCKTAIL, NCT04108104: Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects

Completed
2
154
Europe
Cyproheptadine, Periactine®, Alpress LP, Prazosin
Kinnov Therapeutics, ECSOR
Alcohol Use Disorder
10/21
01/22

Download Options